Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

• Published in: Nature communications Vol. 11; no. 1; pp. 1 - 13
• Main Authors: Lee, Giljae, You, Hyun Ju, Bajaj, Jasmohan S., Joo, Sae Kyung, Yu, Junsun, Park, Seoyeon, Kang, Hyena, Park, Jeong Hwan, Kim, Jung Ho, Lee, Dong Hyeon, Lee, Seonhwa, Kim, Won, Ko, GwangPyo
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 05.10.2020; Nature Publishing Group; Nature Portfolio
• Subjects: 38/22; 45; 45/23; 45/77; 631/326/2565/2134; 64/60; 692/53/2421; 692/699/1503/1607/1605; 82/58; Animal models; Bile acids; Biopsy; Digestive system; Fatty liver; Fibrosis; Humanities and Social Sciences; Intestinal microflora; Liver; Liver diseases; Metabolites; Microbiomes; Microbiota; multidisciplinary; Obesity; Pathogenesis; Propionic acid; rRNA 16S; Ruminococcaceae; Science; Science (multidisciplinary); Signatures; Subgroups; Veillonellaceae
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-020-18754-5

Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. Gut microbiome profiles of 171 Asians with biopsy-proven NAFLD and 31 non-NAFLD controls are analyzed using 16S rRNA sequencing; an independent Western cohort is used for external validation. Subjects are classified into three subgroups according to histological spectra of NAFLD or fibrosis severity. Significant alterations in microbiome diversity are observed according to fibrosis severity in non-obese, but not obese, subjects. Ruminococcaceae and Veillonellaceae are the main microbiota associated with fibrosis severity in non-obese subjects. Furthermore, stool bile acids and propionate are elevated, especially in non-obese subjects with significant fibrosis. Fibrosis-related Ruminococcaceae and Veillonellaceae species undergo metagenome sequencing, and four representative species are administered in three mouse NAFLD models to evaluate their effects on liver damage. This study provides the evidence for the role of the microbiome in the liver fibrosis pathogenesis, especially in non-obese subjects. Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in individuals without obesity. Here, gut microbiome analysis using a biopsy-proven NAFLD cohort reveal distinct signatures of microbiome-metabolites associated with significant fibrosis in patients with NAFLD without obesity.